Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
All APAC Global
All APAC Global
All APAC Global
All APAC Global
PharmAbcine Announces Collaboration Agreement with MSD to Evaluate Anti-VISTA Antibody PMC-309 in Combination with KEYTRUDA® (pembrolizumab) 2022-12-12 21:00
Asieris'Bladder Cancer Diagnostic Drug Hexvix® Completed Dosing of First Patient in Real-World Clinical Study 2022-12-12 20:59
JW Therapeutics Presents Latest Clinical Data on Carteyva® in Follicular Lymphoma and Mantle Cell Lymphoma at the 64th ASH Annual Meeting 2022-12-12 18:00
HitGen Announces Research Agreement with Nitrase Therapeutics Focused on DNA-Encoded Library Based Drug Discovery 2022-12-12 10:10
Gracell Biotechnologies Presents Clinical Data for FasTCAR-T GC012F for High Risk, Newly Diagnosed Multiple Myeloma Demonstrating 100% Overall Response Rate 2022-12-11 07:15
Goodwin Biotechnology Inc. is now GBI, as Part of their Rebranding Initiative on their 30-Year Anniversary! 2022-12-10 04:16
Treadwell Therapeutics Announces A Presentation at the 2022 SABCS Annual Meeting Featuring a Clinical Trial Update on CFI-402257, a Best-in-Class TTK inhibitor 2022-12-09 22:30
Shenzhen Holds 2022 Global Investment Promotion Conference to Build a Magnet for International Investors 2022-12-09 11:16
Antengene Announces HREC Approval in Australia for the Phase I Trial of ATG-022 (Claudin 18.2 ADC) in Patients with Advanced or Metastatic Solid Tumors 2022-12-09 08:30
SK Biopharmaceuticals' Partner Angelini Pharma Launches Cenobamate in France 2022-12-09 06:30
ReviR Therapeutics to Present at RNA Targeted Drug Discovery Summit 2022-12-08 23:00
LISCure's Phase 2 Drug Candidate Granted Orphan Drug Designation (ODD) from US FDA 2022-12-08 22:00
PharmAbcine to Participate in the 41th Annual J.P. Morgan Healthcare Conference and Biotech Showcase™ 2023 during JPM Week 2022-12-08 21:00
CABIO Showcases the Latest Research Results and Innovative Solutions at Food Ingredients Europe 2022 2022-12-08 21:00
Createrna Announces Positive Top-Line Results from Phase 1 Clinical Trials of QR052107B Tablet in Healthy Volunteers 2022-12-08 14:29
PGTG successfully develops SGF bone-derived factor to restore the skeletal system 2022-12-07 12:00
Turn Biotechnologies Changes Paradigm in Skin Rejuvenation 2022-12-06 22:00
Newtown's Apple to Highly Saturated Global Molecular Market, TIANGEN TGuide S16 Automated Nucleic Acid Extractor Showcased at Cell Bio 2022 2022-12-06 21:04
Akeso Inc. Announces Collaboration and License Agreement for Up to US$5 Billion with Summit Therapeutics to Accelerate Global Development and Commercialization of its Breakthrough Bispecific Antibody, Ivonescimab (PD-1/VEGF) 2022-12-06 21:01
Daewoong Pharmaceutical announces success in developing a new antidiabetic medication and its aims to enter the market in over 50 countries by 2030 2022-12-06 20:00
1 137 138 139 140 141 452